Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 5 Lung Neoplasms 3 Breast Neoplasms 3 Pancreatic Neoplasms 2 Multiple Myeloma 2 Gastrointestinal Neoplasms 2 Uterine Cervical Neoplasms 1 Support of the Family as a Caregiving System 1 Stomach Neoplasms 1 Quality of Life 1 Pseudomyxoma Peritonei 1 Prostatic Neoplasms 1 Paranasal Sinus Neoplasms 1 Papillomavirus Infections 1 Pain 1 Otorhinolaryngologic Neoplasms 1 Oropharyngeal Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Mixed Dementias 1 Mesothelioma, Malignant 1 Meningeal Carcinomatosis 1 Maxillary Sinus Neoplasms 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Follicular 1 Lymphoma 1 Localized Head and Neck Carcinoma 1 Lewy Body Disease 1

Interventions

Temozolomide 162 Radiosurgery 115 Radiotherapy 100 Bevacizumab 96 Magnetic Resonance Spectroscopy 65 Carboplatin 48 Etoposide 34 pembrolizumab 33 Surgical Procedures, Operative 33 Irinotecan 33 Nivolumab 32 Cyclophosphamide 32 Erlotinib Hydrochloride 31 Radiation 30 Carmustine 28 Cisplatin 25 Lomustine 24 Trastuzumab 23 Ipilimumab 23 Filgrastim 23 Vincristine 20 Mental Status and Dementia Tests 20 Aminolevulinic Acid 19 Topotecan 18 Pemetrexed 18 Capecitabine 18 Specimen Handling 17 Sorafenib 15 Radiotherapy, Intensity-Modulated 15 Imatinib Mesylate 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Brain Neoplasms × Referral and Consultation × Clear all

NCT05404308 2025-09-17

MERMOSE

Centre Francois Baclesse

Phase NA Active not recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡